[1] Vanier MT. Niemann-Pick disease type C[J]. Orphanet J Rare Dis, 2010, 5(2):16-20. [2] Fernandez-Valero EM, Ballart A, Iturriaga C, et al. Identification of 25 new mutations in 40 unrelated Spanish Niemann-Pick type C patients:Genotype-phenotype correlations[J]. Clin Genet,2005, 68(3):245-254. [3] Geberhiwot T, Moro A, Dardis A, et al. Consensus clinical management guidelines for Niemann-Pick disease type C[J]. Orphanet J Rare Dis, 2018, 13(1):50-53. [4] Seker Yilmaz B, Baruteau J, Rahim AA, et al. Clinical and molecular features of early infantile Niemann Pick type C disease[J]. Int J Mol Sci, 2020, 21(14):50-59. [5] Spiegel R, Raas-Rothschild A, Reish O, et al. The clinical spectrum of fetal Niemann-Pick type C[J]. Am J Med Genet A, 2009, 149(3):446-450. [6] Patterson MC, Hendriksz CJ, Walterfang M, et al. Recommendations for the diagnosis and management of Niemann-Pick disease type C:An update[J], Mol Genet Metab. 2012, 106(3):330-344. [7] Wraith JE, Vecchio D, Jacklin E, et al. Miglustat in adult and juvenile patients with Niemann-Pick disease type C:Long-term data from a clinical trial[J]. Mol Genet Metab,2010, 99(4):351-357. [8] Patterson MC, Garver WS, Giugliani R, et al. Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: A large retrospective observational study[J]. J Inherit Metab Dis,2020, 43(5):1060-1069. [9] Hassani MA, Alami M, Baba AF, et al. Niemann Pick disease A: a case report[J]. Ann Biol Clin,2010, 68(6):733-735. [10] Schneiderman J, Thormann K, Charrow J, et al. Correction of enzyme levels with allogeneic hematopoeitic progenitor cell transplantation in Niemann-Pick type B[J]. Pediatr Blood Cancer,2007, 49(7):987-989. [11] Hughes MP, Smith DA, Morris L, et al. AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease[J]. Hum Mol Genet,2018, 27(17):3079-3098.
PDF(1340 KB)
